April 20, 2026 Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
April 20, 2026 RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue
April 20, 2026 Group Coaching Weekly Launches Live Program Focused on Structured Thinking and Real-Time Growth
April 20, 2026 Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile